Sustained-release preparation containing felodipine and preparation method thereof
A technology for sustained-release preparations and sustained-release excipients, which is applied in the directions of medical preparations containing active ingredients, medical preparations without active ingredients, and pharmaceutical formulas, which can solve the problems of slow release and incomplete release, and achieve complete and Guarantee the effect of continuous release and solve the release problem
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Preparation Process:
[0020] Hypromellose K100M CR was crushed through a 160-mesh sieve, felodipine was crushed through a 100-mesh sieve, microcrystalline cellulose PH102 and lactose were respectively passed through a 80-mesh sieve, and magnesium stearate was passed through a 60-mesh sieve. Mix felodipine, hypromellose K100M CR, microcrystalline cellulose PH102 and lactose evenly, and then use the aqueous solution of hypromellose K4M CR to make a soft material. After granulation, drying and sizing, finally add magnesium stearate and mix well, 7mm shallow concave punched tablets (141mg / tablet), and use Opadry for film coating.
Embodiment 2
[0023] Preparation Process:
[0024] Hypromellose K100M CR is crushed through a 160-mesh sieve, felodipine is crushed through a 100-mesh sieve, microcrystalline cellulose PH102 and lactose are respectively passed through a 80-mesh sieve, magnesium stearate is passed through a 60-mesh sieve, and silicon dioxide is passed through a 40-mesh sieve screen. Mix felodipine, hypromellose K100MCR, microcrystalline cellulose PH102 and lactose evenly, and then use 50% ethanol aqueous solution as a wetting agent to make a soft material. After granulation, drying and sizing, finally add silicon dioxide and magnesium stearate and mix evenly, 7mm shallow concave punched tablets (145mg / tablet), and use Opadry for film coating.
Embodiment 3
[0027] Preparation Process:
[0028] Hypromellose K100M CR and Hypromellose K4M CR were crushed through a 160-mesh sieve, microcrystalline cellulose PH102 and lactose were respectively passed through a 80-mesh sieve, and magnesium stearate was passed through a 60-mesh sieve. Felodipine and povidone K30 were dissolved in absolute ethanol solution. Mix hypromellose K100M CR, hypromellose K4M CR, microcrystalline cellulose PH102 and lactose evenly, then stir with the mixed solution of raw and auxiliary materials to make soft material. If the soft material is too dry, add 50 % ethanol aqueous solution. After granulation, drying and sizing, finally add magnesium stearate and mix well, 7mm shallow concave punched tablets (145mg / tablet), and use Opadry for film coating.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com